Ghrelin and cancer

Molecular and Cellular Endocrinology

Volumn 340, Issue 1, 2011, Pages 65-69

  Chopin, Lisa ^a   Walpole, Carina ^a   Seim, Inge ^a   Cunningham, Peter ^a   Murray, Rachael ^a   Whiteside, Eliza ^a   Josh, Peter ^a,b   Herington, Adrian ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b CSIRO   (Australia)

Author keywords

Apoptosis; Cancer; Cell migration and invasion; Ghrelin; Growth hormone secretagogue receptor; Proliferation

Indexed keywords

GHRELIN; GROWTH HORMONE SECRETAGOGUE RECEPTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CANCER GROWTH; CELL COUNT; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONCENTRATION RESPONSE; DRUG EFFICACY; HORMONE RESPONSE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

ANIMALS; AUTOCRINE COMMUNICATION; GHRELIN; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; PARACRINE COMMUNICATION;

EID: 79958140525     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.04.013     Document Type: Review

References (73)

1. Adams E.F., Huang B., Buchfelder M., Howard A., Smith R.G., Feighner S.D., van der Ploeg L.H., Bowers C.Y., Fahlbusch R. Presence of growth hormone secretagogue receptor messenger ribonucleic acid in human pituitary tumors and rat GH3 cells. J. Clin. Endocrinol. Metab. 1998, 83:638-642.
2. An J.Y., Choi M.G., Noh J.H., Sohn T.S., Jin D.K., Kim S. Clinical significance of ghrelin concentration of plasma and tumor tissue in patients with gastric cancer. J. Surg. Res. 2007, 143:344-349.
3. Andreis P., Malendowicz L., Trejter M., Neri G., Spinazzi R., Rossi G., Nussdorfer G. Ghrelin and growth hormone secretagogue receptor are expressed in the rat adrenal cortex: evidence that ghrelin stimulates the growth, but not the secretory activity of adrenal cells. FEBS Lett. 2003, 536:173-179.
4. Aydin S., Ozercan I.H., Dagli F., Dogru O., Celebi S., Akin O., Guzel S.P. Ghrelin immunohistochemistry of gastric adenocarcinoma and mucoepidermoid carcinoma of salivary gland. Biotech. Histochem. 2005, 80:163-168.
5. Baldanzi G., Filigheddu N., Cutrupi S., Catapano F., Bonissoni S., Fubini A., Malan D., Baj G., Granata R., Broglio F., Papotti M., Surico N., Bussolino F., Isgaard J., Deghenghi R., Sinigaglia F., Prat M., Muccioli G., Ghigo E., Graziani A. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J. Cell Biol. 2002, 159:1029-1037.
6. Barzon L., Pacenti M., Masi G., Stefani A.L., Fincati K., Palu G. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors. Oncology 2005, 68:414-421.
7. Belloni A.S., Macchi C., Rebuffat P., Conconi M.T., Malendowicz L.K., Parnigotto P.P., Nussdorfer G.G. Effect of ghrelin on the apoptotic deletion rate of different types of cells cultured in vitro. Int. J. Mol. Med. 2004, 14:165-167.
8. Camina J.P. Cell biology of the ghrelin receptor. J. Neuroendocrinol. 2006, 18:65-76.
9. Cassoni P., Allia E., Marrocco T., Ghe C., Ghigo E., Muccioli G., Papotti M. Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line. J. Endocrinol. Invest. 2006, 29:781-790.
10. Cassoni P., Ghe C., Marrocco T., Tarabra E., Allia E., Catapano F., Deghenghi R., Ghigo E., Papotti M., Muccioli G. Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur. J. Endocrinol. 2004, 150:173-184.
11. Cassoni P., Papotti M., Ghe C., Catapano F., Sapino A., Graziani A., Deghenghi R., Reissmann T., Ghigo E., Muccioli G. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J. Clin. Endocrinol. Metab. 2001, 86:1738-1745.
12. Chambers A.F. MDA-MB-435 and M14 cell lines: identical but not M14 melanoma?. Cancer Res. 2009, 69:5292-5293.
13. Chung H., Kim E., Lee D.H., Seo S., Ju S., Lee D., Kim H., Park S. Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation. Endocrinology 2007, 148:148-159.
14. Dagli A.F., Aydin S., Karaoglu A., Akpolat N., Ozercan I.H., Ozercan M.R. Ghrelin expression in normal kidney tissue and renal carcinomas. Pathol. Res. Pract. 2009, 205:165-173.
15. De Vriese C., Delporte C. Ghrelin: a new peptide regulating growth hormone release and food intake. Int. J. Biochem. Cell Biol. 2008, 40:1420-1424.
16. De Vriese C., Gregoire F., De Neef P., Robberecht P., Delporte C. Ghrelin is produced by the human erythroleukemic HEL cell line and involved in an autocrine pathway leading to cell proliferation. Endocrinology 2005, 146:1514-1522.
17. De Vriese C., Gregoire F., Lema-Kisoka R., Waelbroeck M., Robberecht P., Delporte C. Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology 2004, 145:4997-5005.
18. Delhanty P.J., van Koetsveld P.M., Gauna C., van de Zande B., Vitale G., Hofland L.J., van der Lely A.J. Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E302-E309.
19. Diaz-Lezama N., Hernandez-Elvira M., Sandoval A., Monroy A., Felix R., Monjaraz E. Ghrelin inhibits proliferation and increases T-type Ca2+ channel expression in PC-3 human prostate carcinoma cells. Biochem. Biophys. Res. Commun. 2010, 403:24-29.
20. Dixit V.D., Weeraratna A.T., Yang H., Bertak D., Cooper-Jenkins A., Riggins G.J., Eberhart C.G., Taub D.D. Ghrelin and the growth hormone secretagogue receptor constitute a novel autocrine pathway in astrocytoma motility. J. Biol. Chem. 2006, 281:16681-16690.
21. Duxbury M. Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness. Biochem. Biophys. Res. Commun. 2003, 309:464-468.
22. Ekeblad S., Lejonklou M.H., Grimfjard P., Johansson T., Eriksson B., Grimelius L., Stridsberg M., Stalberg P., Skogseid B. Co-expression of ghrelin and its receptor in pancreatic endocrine tumours. Clin. Endocrinol. (Oxf.) 2007, 66:115-122.
23. Ekeblad S., Nilsson B., Lejonklou M.H., Johansson T., Stalberg P., Nilsson O., Ahlman H., Skogseid B. Gastrointestinal stromal tumors express the orexigen ghrelin. Endocr. Relat. Cancer 2006, 13:963-970.
24. Fung J., Seim I., Wang D., Obermair A., Chopin L.K., Chen C. Expression and in vitro functions of the ghrelin axis in endometrial cancer. Hormones Cancer 2010, 1:245-255.
25. Gaytan F, Barreiro M.L., Caminos J.E., Chopin L.K., Herington A.C., Morales C., Pinilla L., Paniagua R., Nistal M., Casanueva F.F., Aguilar E., Dieguez C., Tena-Sempere M. Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors. J. Clin. Endocrinol. Metab. 2004, 89:400-409.
26. Gaytan F., Morales C., Barreiro M.L., Jeffery P., Chopin L.K., Herington A.C., Casanueva F.F., Aguilar E., Dieguez C., Tena-Sempere M. Expression of growth hormone secretagogue receptor type 1a, the functional ghrelin receptor, in human ovarian surface epithelium, mullerian duct derivatives, and ovarian tumors. J. Clin. Endocrinol. Metab. 2005, 90:1798-1804.
27. Ghe C., Cassoni P., Catapano F., Marrocco T., Deghenghi R., Ghigo E., Muccioli G., Papotti M. The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. Endocrinology 2002, 143:484-491.
28. Gnanapavan S., Kola B., Bustin S., Morris D., McGee P., Fairclough P., Bhattacharya S., Carpenter R., Grossman A., Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab. 2002, 87:2988.
29. Granata R, Settanni F., Biancone L., Trovato L., Nano R., Bertuzzi F., Destefanis S., Annunziata M., Martinetti M., Catapano F., Ghe C., Isgaard J., Papotti M., Ghigo E., Muccioli G. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling. Endocrinology 2007, 148:512-529.
30. Gualillo O., Caminos J., Blanco M., Garcia-Caballero T., Kojima M., Kangawa K., Dieguez C., Casanueva F. Ghrelin, a novel placental-derived hormone. Endocrinology 2001, 142:788-794.
31. Hanahan D., Weinberg R. The hallmarks of cancer. Cell 2000, 100:57-70.
32. Hosoda H., Doi K., Nagaya N., Okumura H., Nakagawa E., Enomoto M., Ono F., Kangawa K. Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples. Clin. Chem. 2004, 50:1077-1080.
33. Howard A., Feighner S., Cully D., Arena J., Liberator P., Rosenblum C., Hamelin M., Hreniuk D., Palyha O., Anderson J., Paress P., Diaz C., Chou M., Liu K., McKee K., Pong S., Chuang L., Elbrecht A., Dashkevicz M., Heavens R., Rigby M., Sirinathsinghji D., Dean D., Melillo D., Patchett A., Nargund R., Grifin P., DeMartino J., Gupta S., Schaefer J., Smith R., Van der Ploeg L. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 12:137-145.
34. Iwakura H., Hosoda K., Doi R., Komoto I., Nishimura H., Son C., Fujikura J., Tomita T., Takaya K., Ogawa Y., Hayashi T., Inoue G., Akamizu T., Hosoda H., Kojima M., Kangawa K., Imamura M., Nakao K. Ghrelin expression in islet cell tumors: augmented expression of ghrelin in a case of glucagonoma with multiple endocrine neoplasm type I. J. Clin. Endocrinol. Metab. 2002, 87:4885-4888.
35. Jeffery P., Herington A., Chopin L. The potential autocrine/paracrine roles of ghrelin and its receptor in hormone dependent cancer. Cytokine Growth Factor Rev. 2003, 14:113-122.
36. Jeffery P, Murray R., Yeh A., McNamara J., Duncan R.P., Francis G., Herington A., Chopin L. Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocr. Relat. Cancer 2005, 12:839-850.
37. Jeffery P.L., Herington A.C., Chopin L.K. Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J. Endocrinol. 2002, 172:R7-11.
38. Kim K., Arai K., Sanno N., Osamura R.Y., Teramoto A., Shibasaki T. Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas. Clin. Endocrinol. (Oxf.) 2001, 54:759-768.
39. Kim M.S., Yoon C.Y., Jang P.G., Park Y.J., Shin C.S., Park H.S., Ryu J.W., Pak Y.K., Park J.Y., Lee K.U., Kim S.Y., Lee H.K., Kim Y.B., Park K.S. The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol. Endocrinol. 2004, 18:2291-2301.
40. Kim S.W., Her S.J., Park S.J., Kim D., Park K.S., Lee H.K., Han B.H., Kim M.S., Shin C.S., Kim S.Y. Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells. Bone 2005, 37:359-369.
41. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
42. Kojima M., Kangawa K. Ghrelin: structure and function. Physiol. Rev. 2005, 85:495-522.
43. Konturek P.C., Burnat G., Rau T., Hahn E.G., Konturek S. Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line. Dig. Dis. Sci. 2008, 53:597-605.
44. Korbonits M., Bustin S., Kojima M., Jordan S., Adams E., Lowe D., Kangawa K., Grossman A. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumours. J. Clin. Endocrinol. Metab. 2001, 86:881-887.
45. Korbonits M., Jacobs R.A., Aylwin S.J., Burrin J.M., Dahia P.L., Monson J.P., Honegger J., Fahlbush R., Trainer P.J., Chew S.L., Besser G.M., Grossman A.B. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors. J. Clin. Endocrinol. Metab. 1998, 83:3624-3630.
46. Kui L., Weiwei Z., Ling L., Daikun H., Guoming Z., Linuo Z., Renming H. Ghrelin inhibits apoptosis induced by high glucose and sodium palmitate in adult rat cardiomyocytes through the PI3K-Akt signaling pathway. Regul. Pept. 2009, 155:62-69.
47. Lanfranco F., Baldi M., Cassoni P., Bosco M., Ghe C., Muccioli G. Ghrelin and prostate cancer. Vitam. Horm. 2008, 77:301-324.
48. Maccarinelli G., Sibilia V., Torsello A., Raimondo F., Pitto M., Giustina A., Netti C., Cocchi D. Ghrelin regulates proliferation and differentiation of osteoblastic cells. J. Endocrinol. 2005, 184:249-256.
49. Mazzocchi G., Neri G., Rucinski M., Rebuffat P., Spinazzi R., Malendowicz L.K., Nussdorfer G.G. Ghrelin enhances the growth of cultured human adrenal zona glomerulosa cells by exerting MAPK-mediated proliferogenic and antiapoptotic effects. Peptides 2004, 25:1269-1277.
50. Murata M., Okimura Y., Iida K., Matsumoto M., Sowa H., Kaji H., Kojima M., Kangawa K., Chihara K. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J. Biol. Chem. 2002, 277:5667-5674.
51. Nanzer A., Khalaf S., Mozid A., Fowkes R., Patel M., Burrin J., Grossman A., Korbonits M. Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway. Eur. J. Endocrinol. 2004, 151:233-240.
52. Nikolopoulos D., Theocharis S., Kouraklis G. Ghrelin: a potential therapeutic target for cancer. Regul. Pept. 2010, 163:7-17.
53. Papotti M., Cassoni P., Volante M., Deghenghi R., Muccioli G., Ghigo E. Ghrelin-producing endocrine tumors of the stomach and intestine. J. Clin. Endocrinol. Metab. 2001, 86:5052-5059.
54. Park Y.J., Lee Y.J., Kim S.H., Joung D.S., Kim B.J., So I., Park do J., Cho B.Y. Ghrelin enhances the proliferating effect of thyroid stimulating hormone in FRTL-5 thyroid cells. Mol. Cell. Endocrinol. 2008, 285:19-25.
55. Pettersson I., Muccioli G., Granata R., Deghenghi R., Ghigo E., Ohlsson C., Isgaard J. Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2 cardiomyocyte cell proliferation. J. Endocrinol. 2002, 175:201-209.
56. Rak-Mardyla A., Gregoraszczuk E. Effect of ghrelin on proliferation, apoptosis and secretion of progesterone and hCG in the placental JEG-3 cell line. Reprod. Biol. 2010, 10:159-165.
57. Seim I., Josh P., Cunningham P., Herington A., Chopin L. Ghrelin axis genes, peptides and receptors: Recent findings and future challenges. Mol. Cell. Endocrinol. 2011, 340:3-9.
58. Skinner M., Nass R., Lopes B., Laws E., Thorner M. Growth hormone secretagogue receptor expression in human pituitary tumors. J. Clin. Endocrinol. Metab. 1998, 83:4314-4320.
59. Soares J.B., Leite-Moreira A.F. Ghrelin, des-acyl ghrelin and obestatin: three pieces of the same puzzle. Peptides 2008, 29:1255-1270.
60. Takahashi K., Furukawa C., Takano A., Ishikawa N., Kato T., Hayama S., Suzuki C., Yasui W., Inai K., Sone S., Ito T., Nishimura H., Tsuchiya E., Nakamura Y., Daigo Y. The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer. Cancer Res. 2006, 66:9408-9419.
61. Ueberberg B., Unger N., Sheu S.Y., Walz M.K., Schmid K.W., Saeger W., Mann K., Petersenn S. Differential expression of ghrelin and its receptor (GHS-R1a) in various adrenal tumors and normal adrenal gland. Horm. Metab. Res. 2008, 40:181-188.
62. Ueberberg B., Unger N., Saeger W., Mann K., Petersenn S. Expression of ghrelin and its receptor in human tissues. Horm. Metab. Res. 2009, 41:814-821.
63. Volante M., Allia E., Fulcheri E., Cassoni P., Ghigo E., Muccioli G., Papotti M. Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth. Am. J. Pathol. 2003, 162:645-654.
64. Volante M., Allia E., Gugliotta P., Funaro A., Broglio F., Deghenghi R., Muccioli G., Ghigo E., Papotti M. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J. Clin. Endocrinol. Metab. 2002, 87:1300-1308.
65. Wang D.H., Hu Y.S., Du J.J., Hu Y.Y., Zhong W.D., Qin W.J. Ghrelin stimulates proliferation of human osteoblastic TE85 cells via NO/cGMP signaling pathway. Endocrine 2009, 35:112-117.
66. Waseem T., Javaid Ur R., Ahmad F., Azam M., Qureshi M.A. Role of ghrelin axis in colorectal cancer: a novel association. Peptides 2008, 29:1369-1376.
67. Wasko R., Jaskula M., Kotwicka M., Andrusiewicz M., Jankowska A., Liebert W., Sowinski J. The expression of ghrelin in somatotroph and other types of pituitary adenomas. Neuro Endocrinol. Lett. 2008, 29:929-938.
68. Wasko R., Jaskula M., Plewa R., Komarowska H., Poreba E., Gozdzicka-Jozefiak A., Liebert W., Bednarek J., Sowinski J. The evaluation of ghrelin mRNA expression in human somatotroph adenomas. Neuro Endocrinol. Lett. 2006, 27:169-173.
69. Xia Q., Pang W., Pan H., Zheng Y., Kang J.S., Zhu S.G. Effects of ghrelin on the proliferation and secretion of splenic T lymphocytes in mice. Regul. Pept. 2004, 122:173-178.
70. Yang M., Hu S., Wu B., Miao Y., Pan H., Zhu S. Ghrelin inhibits apoptosis signal-regulating kinase 1 activity via upregulating heat-shock protein 70. Biochem. Biophys. Res. Commun. 2007, 359:373-378.
71. Yeh A., Jeffery P.L., Duncan R.P., Herington A., Chopin L. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Clin. Cancer Res. 2005, 11:8295-8303.
72. Zhang Y., Ying B., Shi L., Fan H., Yang D., Xu D., Wei Y., Hu X., Zhang X., Wang T., Liu D., Dou L., Chen G., Jiang F., Wen F. Ghrelin inhibit cell apoptosis in pancreatic beta cell line HIT-T15 via mitogen-activated protein kinase/phosphoinositide 3-kinase pathways. Toxicology 2007, 237:194-202.
73. Zub-Pokrowiecka A., Rembiasz K., Konturek S.J., Budzynski A., Konturek P.C., Budzynski P. Ghrelin in diseases of the gastric mucosa associated with Helicobacter pylori infection. Med. Sci. Monitor 2010, 16:CR493-CR500.